Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000780409 | SCV000917632 | uncertain significance | not specified | 2017-12-20 | criteria provided, single submitter | clinical testing | Variant summary: The MEFV c.1759+7C>T variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a polymorphism outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 14/246198 control chromosomes (gnomAD) at a frequency of 0.0000569, which does not exceed the estimated maximal expected allele frequency of a pathogenic MEFV variant (0.0216506). The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Because of the absence of clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS). |
Invitae | RCV001825529 | SCV002399663 | likely benign | Familial Mediterranean fever | 2023-11-15 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002263974 | SCV002543719 | uncertain significance | Autoinflammatory syndrome | 2017-01-03 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001825529 | SCV002087386 | uncertain significance | Familial Mediterranean fever | 2019-10-28 | no assertion criteria provided | clinical testing |